NCT04703803View on ClinicalTrials.gov

Efficacy of Myofascial Pain Syndrome Treatment in Patients With Cancer in Palliative Care

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 17, 2020

Primary Completion Date

March 19, 2021

Study Completion Date

May 17, 2022

Conditions
Myofascial Pain SyndromesCancer
Interventions
COMBINATION_PRODUCT

1% lidocaine injection in trigger points

The trigger point injection procedure with 1% lidocaine will be e (the sum of all needled trigger points will have a maximum of 10 ml), in a single intervention

Trial Locations (1)

14048900

Laís Araujo Dos Santos Vilar, Ribeirão Preto

All Listed Sponsors
lead

University of Sao Paulo

OTHER

NCT04703803 - Efficacy of Myofascial Pain Syndrome Treatment in Patients With Cancer in Palliative Care | Biotech Hunter | Biotech Hunter